Cargando…

SAT-254 Desmopressin Stimulation Test in a Pregnant Patient with Cushing’s Syndrome

Background: Cushing’s syndrome (CS) in pregnancy is a rare condition. Accurate diagnosis and appropriate treatment are necessary due to increased morbidity and mortality in the fetus and mother with active CS. However, hormonal changes during pregnancy and limitations in terms of teratogenicity comp...

Descripción completa

Detalles Bibliográficos
Autores principales: Warachit, Wasita, Porntharukchareon, Thachanun, Sunthornyothin, Sarat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208738/
http://dx.doi.org/10.1210/jendso/bvaa046.1771
_version_ 1783530916456431616
author Warachit, Wasita
Porntharukchareon, Thachanun
Sunthornyothin, Sarat
author_facet Warachit, Wasita
Porntharukchareon, Thachanun
Sunthornyothin, Sarat
author_sort Warachit, Wasita
collection PubMed
description Background: Cushing’s syndrome (CS) in pregnancy is a rare condition. Accurate diagnosis and appropriate treatment are necessary due to increased morbidity and mortality in the fetus and mother with active CS. However, hormonal changes during pregnancy and limitations in terms of teratogenicity complicates the diagnosis of CS. Clinical case: A 27-year-old female presented at gestational age (GA) of 8 weeks with a 2-month history of proximal muscle weakness. She had 20-kg weight gain in 2 years before hypertension, prediabetes and pulmonary tuberculosis developed at the age of 25. On physical examination, her blood pressure was 160/100 mmHg. She had moon face, buffalo hump, wide purplish striae and hirsutism without signs of virilization. At GA 9 weeks, her morning cortisol was 32 μ;g/dL (883 nmol/L). Her salivary cortisol was 0.7 μ;g/dL (19 nmol/L) and a mean 24-hour urinary free cortisol was 237 μ;g/d (654 nmol/d), which were above reference ranges. Adrenocorticotropic hormone (ACTH) were 48 pg/mL (11 pmol/L) and 40 pg/mL (9 pmol/L). Dehydroepiandrosterone sulphate was 378 μ;g/dL (10 nmol/L). A non-gadolinium enhanced magnetic resonance imaging (MRI) at GA 12 weeks did not reveal a pituitary mass. Desmopressin stimulation test was carried out at GA 14 weeks. Her baseline cortisol was 31 μ;g/dL (855 nmol/L) and ACTH was 35 pg/mL (8 pmol/L). Her ACTH increased 70% at 15 minutes after desmopressin stimulation, with an absolute difference between basal and peak ACTH of 24 pg/mL (5 pmol/L). MRI pituitary gland with gadolinium at GA 14 weeks revealed an 8-mm adenoma at right inferolateral aspect of pituitary gland. Transsphenoidal surgery with selective adenomectomy was done at GA 18 weeks without immediate complications. Pathological findings showed a segment of pituitary adenoma with ACTH positive cells. After surgery, her morning cortisol was 6 μ;g/dL (166 nmol/L). Hydrocortisone supplement was given and had been continued throughout pregnancy. She successfully gave birth to a term 2300-gram male infant. One year after delivery, she had spontaneous pregnancy and also delivered a term 3300-gram male infant. Cushing’s syndrome had been in remission for 2 years of follow-up. Conclusion: Hormonal changes during pregnancy lead to an increased in ACTH after 7 weeks of gestation. Desmopressin test can be a safe and reliable test to differentiate between ACTH-dependent and ACTH-independent CS. Because a non-gadolinium enhanced MRI may not always detect pituitary microadenoma, this raises the necessity of the use of MRI with gadolinium as an initial imaging in pregnant patients with ACTH-dependent CS. References: Brue T, Amodru V, Castinetti F. Management of Cushing’s syndrome during pregnancy: solved and unsolved questions. Eur J Endocrinol. 2018;178(6):R259-266.
format Online
Article
Text
id pubmed-7208738
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-72087382020-05-13 SAT-254 Desmopressin Stimulation Test in a Pregnant Patient with Cushing’s Syndrome Warachit, Wasita Porntharukchareon, Thachanun Sunthornyothin, Sarat J Endocr Soc Neuroendocrinology and Pituitary Background: Cushing’s syndrome (CS) in pregnancy is a rare condition. Accurate diagnosis and appropriate treatment are necessary due to increased morbidity and mortality in the fetus and mother with active CS. However, hormonal changes during pregnancy and limitations in terms of teratogenicity complicates the diagnosis of CS. Clinical case: A 27-year-old female presented at gestational age (GA) of 8 weeks with a 2-month history of proximal muscle weakness. She had 20-kg weight gain in 2 years before hypertension, prediabetes and pulmonary tuberculosis developed at the age of 25. On physical examination, her blood pressure was 160/100 mmHg. She had moon face, buffalo hump, wide purplish striae and hirsutism without signs of virilization. At GA 9 weeks, her morning cortisol was 32 μ;g/dL (883 nmol/L). Her salivary cortisol was 0.7 μ;g/dL (19 nmol/L) and a mean 24-hour urinary free cortisol was 237 μ;g/d (654 nmol/d), which were above reference ranges. Adrenocorticotropic hormone (ACTH) were 48 pg/mL (11 pmol/L) and 40 pg/mL (9 pmol/L). Dehydroepiandrosterone sulphate was 378 μ;g/dL (10 nmol/L). A non-gadolinium enhanced magnetic resonance imaging (MRI) at GA 12 weeks did not reveal a pituitary mass. Desmopressin stimulation test was carried out at GA 14 weeks. Her baseline cortisol was 31 μ;g/dL (855 nmol/L) and ACTH was 35 pg/mL (8 pmol/L). Her ACTH increased 70% at 15 minutes after desmopressin stimulation, with an absolute difference between basal and peak ACTH of 24 pg/mL (5 pmol/L). MRI pituitary gland with gadolinium at GA 14 weeks revealed an 8-mm adenoma at right inferolateral aspect of pituitary gland. Transsphenoidal surgery with selective adenomectomy was done at GA 18 weeks without immediate complications. Pathological findings showed a segment of pituitary adenoma with ACTH positive cells. After surgery, her morning cortisol was 6 μ;g/dL (166 nmol/L). Hydrocortisone supplement was given and had been continued throughout pregnancy. She successfully gave birth to a term 2300-gram male infant. One year after delivery, she had spontaneous pregnancy and also delivered a term 3300-gram male infant. Cushing’s syndrome had been in remission for 2 years of follow-up. Conclusion: Hormonal changes during pregnancy lead to an increased in ACTH after 7 weeks of gestation. Desmopressin test can be a safe and reliable test to differentiate between ACTH-dependent and ACTH-independent CS. Because a non-gadolinium enhanced MRI may not always detect pituitary microadenoma, this raises the necessity of the use of MRI with gadolinium as an initial imaging in pregnant patients with ACTH-dependent CS. References: Brue T, Amodru V, Castinetti F. Management of Cushing’s syndrome during pregnancy: solved and unsolved questions. Eur J Endocrinol. 2018;178(6):R259-266. Oxford University Press 2020-05-08 /pmc/articles/PMC7208738/ http://dx.doi.org/10.1210/jendso/bvaa046.1771 Text en © Endocrine Society 2020. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Neuroendocrinology and Pituitary
Warachit, Wasita
Porntharukchareon, Thachanun
Sunthornyothin, Sarat
SAT-254 Desmopressin Stimulation Test in a Pregnant Patient with Cushing’s Syndrome
title SAT-254 Desmopressin Stimulation Test in a Pregnant Patient with Cushing’s Syndrome
title_full SAT-254 Desmopressin Stimulation Test in a Pregnant Patient with Cushing’s Syndrome
title_fullStr SAT-254 Desmopressin Stimulation Test in a Pregnant Patient with Cushing’s Syndrome
title_full_unstemmed SAT-254 Desmopressin Stimulation Test in a Pregnant Patient with Cushing’s Syndrome
title_short SAT-254 Desmopressin Stimulation Test in a Pregnant Patient with Cushing’s Syndrome
title_sort sat-254 desmopressin stimulation test in a pregnant patient with cushing’s syndrome
topic Neuroendocrinology and Pituitary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208738/
http://dx.doi.org/10.1210/jendso/bvaa046.1771
work_keys_str_mv AT warachitwasita sat254desmopressinstimulationtestinapregnantpatientwithcushingssyndrome
AT porntharukchareonthachanun sat254desmopressinstimulationtestinapregnantpatientwithcushingssyndrome
AT sunthornyothinsarat sat254desmopressinstimulationtestinapregnantpatientwithcushingssyndrome